Non-HDL cholesterol is a single number that captures all the “bad” cholesterol in your blood. You get it by subtracting your HDL (the protective kind) from your total cholesterol. What’s left represents every type of cholesterol particle that can build up in your artery walls and contribute to heart disease. For most adults, a non-HDL level below 130 mg/dL is a reasonable target, though people at higher cardiovascular risk need to aim lower.
How Non-HDL Cholesterol Is Calculated
The math is simple: total cholesterol minus HDL cholesterol equals non-HDL cholesterol. If your total cholesterol is 210 mg/dL and your HDL is 55 mg/dL, your non-HDL is 155 mg/dL. You don’t need a separate blood test for it. Any standard lipid panel gives your doctor everything needed to calculate it.
What makes this number useful is what it includes. LDL cholesterol gets most of the attention, but it’s only one of several harmful particle types circulating in your blood. Non-HDL cholesterol bundles together LDL along with several other players: VLDL (which carries triglycerides), intermediate-density lipoproteins, remnant particles left over after triglycerides are broken down, and lipoprotein(a), a genetically determined particle that raises heart disease risk independently. By lumping all of these into one measurement, non-HDL gives a more complete picture of the cholesterol that can damage your arteries.
Why It May Matter More Than LDL
LDL cholesterol has been the primary target of heart disease prevention for decades, and it remains important. But non-HDL cholesterol consistently outperforms LDL as a predictor of cardiovascular events. Research published in the Journal of the American College of Cardiology found that every cholesterol-carrying particle capable of embedding in artery walls contains a protein called apolipoprotein B. LDL cholesterol only accounts for one type of these particles. Non-HDL captures nearly all of them. When you measure only LDL, you miss the contributions of triglyceride-rich particles that also drive plaque buildup.
This distinction becomes especially important for people already taking cholesterol-lowering medication. A study in The Lancet Regional Health found that non-HDL cholesterol is a better predictor of future heart events than LDL in patients on statins, even when their LDL is well controlled. Some patients hit their LDL target but still have elevated non-HDL, meaning they carry a larger burden of other harmful particles. That residual risk goes undetected if no one checks non-HDL.
Why Non-HDL Is Critical for Diabetes and High Triglycerides
If you have type 2 diabetes, insulin resistance, or metabolic syndrome, non-HDL cholesterol is particularly revealing. The typical cholesterol pattern in diabetes involves high triglycerides, low HDL, and a swarm of small, dense LDL particles, yet the standard LDL number can look relatively normal. This creates a false sense of security. The American Diabetes Association has noted that failing to check non-HDL cholesterol in people with type 2 diabetes can lead to undertreatment.
The reason is straightforward. When triglycerides are elevated, your liver produces more VLDL particles. Those particles and their remnants are atherogenic, meaning they contribute to artery-clogging plaque just like LDL does. Your VLDL level is roughly one-fifth of your triglyceride number. So if your triglycerides are 250 mg/dL, your VLDL is around 50 mg/dL, and that cholesterol is invisible to an LDL-only assessment. Non-HDL catches it.
Target Levels by Risk Category
The most recent joint guidelines from the American College of Cardiology and American Heart Association set non-HDL targets based on your overall cardiovascular risk rather than using a single cutoff for everyone.
- Borderline or intermediate risk (estimated 10-year heart disease risk of 3% to 10%): non-HDL below 130 mg/dL
- High risk (10-year risk of 10% or greater): non-HDL below 100 mg/dL
- Very high risk (people who already have heart disease or have had a cardiovascular event): non-HDL below 85 mg/dL
For children and adolescents, the thresholds are different. A non-HDL level under 120 mg/dL is considered acceptable, 120 to 144 mg/dL is borderline, and 145 mg/dL or above is abnormal. These pediatric ranges matter because cholesterol patterns established in childhood tend to track into adulthood.
Fasting Before Your Blood Test
One practical advantage of non-HDL cholesterol is that it holds up reasonably well without fasting. Several international guidelines now support nonfasting lipid panels because they’re more convenient and avoid the logistical headache of scheduling early-morning blood draws. Your triglycerides do rise somewhat after eating, which can throw off the standard formula used to estimate LDL. But since non-HDL is calculated directly from total cholesterol and HDL, both of which are relatively stable after meals, the measurement stays more reliable.
That said, fasting still matters in certain situations. When LDL needs to be estimated precisely, particularly at low levels or when triglycerides are high, nonfasting samples can lead to misclassification of about 1 in 14 additional patients compared to fasting samples. If your doctor is making treatment decisions based on specific LDL thresholds, they may still ask you to fast for 9 to 12 hours. Non-HDL, though, remains a dependable number either way.
How to Lower Non-HDL Cholesterol
Because non-HDL includes LDL and triglyceride-carrying particles, strategies that lower either one will bring the number down. Diet changes have the most direct impact. Reducing saturated fat from red meat and full-fat dairy products lowers LDL production. Eliminating trans fats, sometimes listed on labels as “partially hydrogenated vegetable oil,” removes one of the most potent drivers of harmful cholesterol. Adding soluble fiber from oatmeal, beans, apples, and pears helps block cholesterol absorption in the gut.
Exercise attacks the problem from the other direction. Regular aerobic activity, roughly 30 minutes of brisk walking five days a week or 25 minutes of vigorous exercise three days a week, raises HDL cholesterol. Since non-HDL is total cholesterol minus HDL, raising HDL effectively lowers the non-HDL number while also improving your overall lipid profile. Losing excess weight, even modest amounts, tends to lower triglycerides and shift particle sizes in a healthier direction.
Omega-3 fatty acids from salmon, mackerel, herring, walnuts, and flaxseeds don’t lower LDL directly, but they help reduce triglycerides and blood pressure, both of which contribute to cardiovascular risk. Moderating alcohol intake also plays a role, as excess drinking raises triglycerides significantly.
When lifestyle changes aren’t enough to reach your target, medication becomes part of the plan. Statins remain the cornerstone of cholesterol treatment and lower both LDL and non-HDL effectively. For people whose non-HDL stays elevated despite statin therapy, additional medications can be added to address the remaining triglyceride-rich particles. The key point is that medication and lifestyle changes work best together. Maintaining healthy habits can allow for lower medication doses and better overall results.
What Makes Non-HDL Worth Tracking
Non-HDL cholesterol fills a gap that LDL alone leaves open. It requires no extra blood work, no special fasting protocol, and no additional cost. It captures the full range of artery-damaging particles in a single, easy-to-calculate number. For anyone with elevated triglycerides, diabetes, or a family history of heart disease, non-HDL provides a more honest assessment of cardiovascular risk than LDL on its own. If your lipid panel results list total cholesterol and HDL, you already have everything you need to check it yourself.